1. 244PBRCA1/BRCA2 predictive genetic testing in an Irish population: A missed opportunity. (23rd October 2018) Authors: Reilly, D E O; Dooley, L; Watson, G; Clarke, R; Nolan, A; Nolan, C; Berkeley, E; Farrell, M P; Gallagher, D Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OS1.7 Genomic attributes of tumor evolution and treatment response in diffuse glioma. (19th September 2018) Authors: Lin, A L; Jonsson, P; Ogilvie, S; Chavan, S; Nolan, C; Gavrilovic, I; Kaley, T; Grommes, C; Pentsova, E; Diamond, E; Daras, M; Stone, J; DeAngelis, L; Tabar, V; Brennan, C; Young, R J; Rosenblum, M; Taylor, B S; Mellinghoff, I K Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 3 Page Start: iii218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Venetoclax, bendamustine, and rituximab in patients with relapsed or refractory NHL: a phase Ib dose-finding study. (28th July 2018) Authors: de Vos, S; Swinnen, L J; Wang, D; Reid, E; Fowler, N; Cordero, J; Dunbar, M; Enschede, S H; Nolan, C; Petrich, A M; Ross, J A; Salem, A H; Verdugo, M; Agarwal, S; Zhou, L; Kozloff, M; Nastoupil, L J; Flowers, C R Journal: Annals of oncology Issue: Volume 29:Number 9(2018) Page Start: 1932 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗